These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38124750)

  • 21. The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
    Zhang J; Chen HM; Ma G; Zhou Z; Raulet D; Rivera AL; Chen SH; Pan PY
    Leukemia; 2019 Aug; 33(8):2078-2089. PubMed ID: 30737483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
    Morris ES; MacDonald KP; Hill GR
    Blood; 2006 May; 107(9):3430-5. PubMed ID: 16380448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.
    Choi J; Cooper ML; Alahmari B; Ritchey J; Collins L; Holt M; DiPersio JF
    PLoS One; 2014; 9(10):e109799. PubMed ID: 25289677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune isolation-enabled nanoencapsulation of donor T cells: a promising strategy for mitigating GVHD and treating AML in preclinical models.
    Mei D; Xue Z; Zhang T; Yang Y; Jin L; Yu Q; Hong J; Zhang X; Ge J; Xu L; Wang H; Zhang Z; Zhao Y; Zhai Y; Tao Q; Zhai Z; Li Q; Li H; Zhang L
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39242117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of regulatory T cells on the graft-versus-leukemia effect.
    Pacini CP; Soares MVD; Lacerda JF
    Front Immunol; 2024; 15():1339318. PubMed ID: 38711496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
    Zhao L; Chen S; Yang P; Cao H; Li L
    Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.
    Asakura S; Hashimoto D; Takashima S; Sugiyama H; Maeda Y; Akashi K; Tanimoto M; Teshima T
    J Clin Invest; 2010 Jul; 120(7):2370-8. PubMed ID: 20530875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in allotransplant immunology.
    Barrett AJ; Rezvani K; Solomon S; Dickinson AM; Wang XN; Stark G; Cullup H; Jarvis M; Middleton PG; Chao N
    Hematology Am Soc Hematol Educ Program; 2003; ():350-71. PubMed ID: 14633790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation].
    Chang YJ; Huang XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):208-11. PubMed ID: 19377632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.
    Nishi Y; Murakami A; Murayama Y; Tsukahara N; Okamoto S; Nakachi S; Morichika K; Tamaki K; Noguchi H; Matsushita M; Karube KN; Fukushima T; Morishima S; Kishimoto H; Masuzaki H
    Transpl Immunol; 2019 Aug; 55():101205. PubMed ID: 30946889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of Graft Anti-Host Cytotoxic T Lymphocytes Along with Allogeneic Bone Marrow Skips Macrophage-Induced Graft-Versus-Host Disease.
    Yoshida R; Yamana H; Hayashi M; Yasuda E; Shibayama Y; Hirose Y; Tanigawa N; Uchiyama K; Kubota T
    J Interferon Cytokine Res; 2021 Sep; 41(9):310-318. PubMed ID: 34543129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.
    Su Y; Sun X; Liu X; Qu Q; Yang L; Chen Q; Liu F; Li Y; Wang Q; Huang B; Huang XJ; Zhang XH
    J Hematol Oncol; 2022 Jul; 15(1):99. PubMed ID: 35864538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
    Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
    Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.
    Schmaltz C; Alpdogan O; Horndasch KJ; Muriglan SJ; Kappel BJ; Teshima T; Ferrara JL; Burakoff SJ; van den Brink MR
    Blood; 2001 May; 97(9):2886-95. PubMed ID: 11313285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.